We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$124B
AUM Growth
+$20B
Cap. Flow
+$16.7B
Cap. Flow %
13.46%
Top 10 Hldgs %
20.91%
Holding
8,008
New
295
Increased
4,222
Reduced
2,579
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 6.83%
2 Financials 5.79%
3 Healthcare 5.06%
4 Consumer Discretionary 4.03%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
326
PUT
ExxonMobil
XOM
$651B
$69M 0.06%
900,900
-249,100
-22% -$19.3M
MS icon
327
CALL
Morgan Stanley
MS
$337B
$68.8M 0.06%
1,571,300
+308,800
+24% +$13.8M
OXY icon
328
PUT
Occidental Petroleum
OXY
$57B
$68.8M 0.06%
1,369,100
+1,316,500
+2,503% +$74.1M
VRTX icon
329
Vertex Pharmaceuticals
VRTX
$121B
$68.6M 0.06%
374,321
+119,212
+47% +$20.8M
UBS icon
330
UBS Group
UBS
$170B
$68.5M 0.06%
5,781,420
-655,542
-10% -$8.03M
MDSO
331
DELISTED
Medidata Solutions, Inc.
MDSO
$68.4M 0.06%
755,871
+738,152
+4,166% +$64.8M
INTC icon
332
PUT
Intel
INTC
$466B
$68.2M 0.06%
1,425,100
-279,400
-16% -$13.9M
ADBE icon
333
PUT
Adobe
ADBE
$89.5B
$68.2M 0.06%
231,500
-47,000
-17% -$13.1M
NEM icon
334
PUT
Newmont
NEM
$98.2B
$68.1M 0.06%
1,770,316
+1,167,616
+194% +$39.5M
BIDU icon
335
CALL
Baidu
BIDU
$35.8B
$67.8M 0.05%
577,700
+236,300
+69% +$33.7M
WMT icon
336
CALL
Walmart Inc
WMT
$871B
$67.5M 0.05%
1,832,100
+912,000
+99% +$31.4M
SRPT icon
337
CALL
Sarepta Therapeutics
SRPT
$1.66B
$67.4M 0.05%
443,500
+369,100
+496% +$44.9M
ETN icon
338
Eaton
ETN
$157B
$67.3M 0.05%
808,473
+249,570
+45% +$20.2M
OXY icon
339
Occidental Petroleum
OXY
$57B
$67.3M 0.05%
1,338,807
+513,195
+62% +$28.9M
GM icon
340
CALL
General Motors
GM
$74.7B
$67M 0.05%
1,740,200
+1,254,700
+258% +$47M
BSX icon
341
Boston Scientific
BSX
$65.8B
$67M 0.05%
1,558,287
+871,015
+127% +$33.5M
MLPC
342
DELISTED
C-Tracks ETNs based on Performance of the Miller/Howard MLP Fundamental Index
MLPC
$66.8M 0.05%
4,932,783
+127,399
+3% +$1.75M
BIIB icon
343
Biogen
BIIB
$29.9B
$66.7M 0.05%
285,073
+101,349
+55% +$23.4M
MS icon
344
Morgan Stanley
MS
$337B
$66.3M 0.05%
1,513,539
+53,435
+4% +$2.38M
CVS icon
345
PUT
CVS Health
CVS
$137B
$66.3M 0.05%
1,216,697
-98,550
-7% -$5.31M
RHT
346
PUT
DELISTED
Red Hat Inc
RHT
$66.1M 0.05%
351,900
+87,000
+33% +$16.1M
VER
347
DELISTED
VEREIT, Inc.
VER
$65.8M 0.05%
1,460,438
-578,374
-28% -$25M
BX icon
348
CALL
Blackstone
BX
$104B
$65.8M 0.05%
1,484,400
+1,145,300
+338% +$45.7M
MDT icon
349
CALL
Medtronic
MDT
$107B
$65.6M 0.05%
673,400
+562,600
+508% +$51.4M
PG icon
350
PUT
Procter & Gamble
PG
$343B
$65M 0.05%
592,900
-615,200
-51% -$65.6M

Similar funds

Citigroup's Q2 2019 Portfolio in Review

As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,222 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.

  • Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
  • Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
  • Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
  • Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
  • Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
  • Citigroup opened 295 new positions and closed 217 in Q2 2019.
  • Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.